Joshua I. Warrick

2.8k total citations
72 papers, 1.6k citations indexed

About

Joshua I. Warrick is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Joshua I. Warrick has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 23 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Joshua I. Warrick's work include Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (26 papers) and Epigenetics and DNA Methylation (12 papers). Joshua I. Warrick is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (26 papers) and Epigenetics and DNA Methylation (12 papers). Joshua I. Warrick collaborates with scholars based in United States, Canada and Sweden. Joshua I. Warrick's co-authors include David J. DeGraff, Jay D. Raman, Lauren Shuman, Matthew Kaag, Nash N. Boutros, Cynthia L. Arfken, Silvana Galderisi, William G. Iacono, Vonn Walter and Guoli Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Joshua I. Warrick

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua I. Warrick United States 22 600 592 278 240 239 72 1.6k
Qiang Ding China 21 179 0.3× 482 0.8× 324 1.2× 233 1.0× 347 1.5× 75 1.3k
Olivier Kerdraon France 17 188 0.3× 298 0.5× 106 0.4× 99 0.4× 171 0.7× 49 1.1k
Dianne Abuelo United States 23 699 1.2× 757 1.3× 199 0.7× 60 0.3× 50 0.2× 52 1.9k
Hiroshi Isozaki Japan 29 987 1.6× 258 0.4× 1.1k 4.0× 158 0.7× 397 1.7× 139 2.2k
Aileen M. Healy United States 13 156 0.3× 567 1.0× 166 0.6× 166 0.7× 106 0.4× 18 1.4k
Yong Wu China 24 267 0.4× 667 1.1× 275 1.0× 513 2.1× 415 1.7× 86 1.6k
Stefano Grosso Italy 18 169 0.3× 667 1.1× 197 0.7× 123 0.5× 145 0.6× 24 1.2k
Amy Webb United States 19 179 0.3× 603 1.0× 318 1.1× 151 0.6× 389 1.6× 67 1.3k
Frederico S. Regateiro Portugal 14 199 0.3× 356 0.6× 74 0.3× 139 0.6× 270 1.1× 41 1.4k

Countries citing papers authored by Joshua I. Warrick

Since Specialization
Citations

This map shows the geographic impact of Joshua I. Warrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua I. Warrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua I. Warrick more than expected).

Fields of papers citing papers by Joshua I. Warrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua I. Warrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua I. Warrick. The network helps show where Joshua I. Warrick may publish in the future.

Co-authorship network of co-authors of Joshua I. Warrick

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua I. Warrick. A scholar is included among the top collaborators of Joshua I. Warrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua I. Warrick. Joshua I. Warrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawrence, Sarah H., Hironobu Yamashita, Lauren Shuman, et al.. (2025). Interferon-γ/Janus Kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer. American Journal Of Pathology. 195(5). 1013–1030. 2 indexed citations
2.
Downes, Michelle R., Katherine Lajkosz, Ferrán Algaba, et al.. (2025). Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study. Histopathology. 87(5). 649–659. 2 indexed citations
3.
Wu, Qingqing, Joshua I. Warrick, David J. DeGraff, et al.. (2024). Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience. Annals of Diagnostic Pathology. 73. 152357–152357. 1 indexed citations
4.
Warrick, Joshua I.. (2024). Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making. Advances in Anatomic Pathology. 31(3). 178–187. 3 indexed citations
5.
Zhu, Yusheng, Sarah Feldman, Michael H. Creer, et al.. (2023). AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis. The Journal of Applied Laboratory Medicine. 8(2). 382–406. 6 indexed citations
6.
Warrick, Joshua I., Hikmat Al‐Ahmadie, David M. Berman, et al.. (2023). International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4. The American Journal of Surgical Pathology. 48(1). e32–e42. 15 indexed citations
7.
Russo, Mariano, Jordan M. Newell, Kathryn Sheldon, et al.. (2020). Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer. 126(12). 2775–2783. 21 indexed citations
8.
Bann, Darrin V., Kathryn Sheldon, Lan Nguyễn, et al.. (2019). Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer. Cancer Research. 79(21). 5490–5499. 20 indexed citations
9.
Pool, Christopher, Vonn Walter, Darrin V. Bann, et al.. (2019). Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 474(3). 341–351. 13 indexed citations
10.
Kim, Yeon, Victoria Jones, Beth L. Worley, et al.. (2019). Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells. Oncogene. 39(8). 1619–1633. 43 indexed citations
11.
Worley, Beth L., Yeon Kim, Kelly E. Leon, et al.. (2018). GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment. Redox Biology. 25. 101051–101051. 45 indexed citations
12.
Joshi, Monika, Leonard Tuanquin, Matthew Kaag, et al.. (2018). Phase Ib study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with urothelial cancer of the bladder: BTCRC-GU15-023 study.. Journal of Clinical Oncology. 36(6_suppl). 455–455. 6 indexed citations
13.
Walter, Vonn, Eugene J. Lengerich, Henry Crist, et al.. (2018). Evidence of a positive association between malpractice climate and thyroid cancer incidence in the United States. PLoS ONE. 13(7). e0199862–e0199862. 16 indexed citations
14.
Yamashita, Hironobu, Lauren Shuman, Joshua I. Warrick, Jay D. Raman, & David J. DeGraff. (2018). Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissue.. PubMed. 6(4). 164–171. 15 indexed citations
15.
Warrick, Joshua I., et al.. (2017). p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC. Molecular Cancer Research. 15(10). 1398–1409. 24 indexed citations
16.
Kocher, Neil J., et al.. (2017). Synchronous Primary Renal Lymphoma and Renal Cell Carcinoma: Collision Tumors in the Same Kidney. Journal of Endourology Case Reports. 3(1). 87–89. 5 indexed citations
17.
Clark, Christine M., et al.. (2017). Atypical Parathyroid Adenoma with Diffuse Fibrosis. Ear Nose & Throat Journal. 96(2). 57–58. 2 indexed citations
18.
Warrick, Joshua I., Matthew Kaag, Jay D. Raman, et al.. (2017). FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(3). 337–345. 44 indexed citations
19.
Warrick, Joshua I., et al.. (2015). Pharyngeal Presentation of Goltz Syndrome: A Case Report with Review of the Literature. Head and Neck Pathology. 10(2). 188–191. 3 indexed citations
20.
Boutros, Nash N., et al.. (2007). The status of spectral EEG abnormality as a diagnostic test for schizophrenia. Schizophrenia Research. 99(1-3). 225–237. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026